LYRA – lyra therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LYRA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/14

07:49 pm

lyra

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

High Report

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Point72 Asset Management, L.P.

Report

11/14

05:49 pm

lyra

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Samsara BioCapital, L.P.

Medium Report

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Samsara BioCapital, L.P.

Report

11/14

05:49 pm

lyra

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.

Medium Report

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P.

Report

11/14

04:55 pm

lyra

Form SCHEDULE 13G/A Lyra Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Medium Report

Form SCHEDULE 13G/A Lyra Therapeutics, Inc. Filed by: Nantahala Capital Management, LLC

Report

11/14

12:01 pm

lyra

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Vestal Point Capital, LP

Medium Report

Form SC 13G/A Lyra Therapeutics, Inc. Filed by: Vestal Point Capital, LP

Report

11/12

04:25 pm

lyra

Form 10-Q Lyra Therapeutics, Inc. For: Sep 30

High Report

Form 10-Q Lyra Therapeutics, Inc. For: Sep 30

Report

11/12

04:19 pm

lyra

Form 8-K Lyra Therapeutics, Inc. For: Nov 12

High Report

Form 8-K Lyra Therapeutics, Inc. For: Nov 12

Report

10/18

04:05 pm

lyra

Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Palasis Maria

Low Report

Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Palasis Maria

Report

10/18

04:05 pm

lyra

Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Cavalier Jason

Low Report

Form 4 Lyra Therapeutics, Inc. For: Oct 16 Filed by: Cavalier Jason

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.